US 2022/0089761 A1 · MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO CD20

Monoclonal antibody that specifically binds to cd20

AssigneeJoint Stock Company “Biocad”

InventorsPavel Andreevich IAKOVLEV, Natalia Eugenievna PESTOVA, Arina Vitalevna ANIKINA, Anna Alexandrovna TRUDOVISHNIKOVA, Mariia Aleksandrovna SHCHEMELEVA, Nina Grachyaevna KHARATIAN, Valery Vladimirovich SOLOVYEV, Alexey Konstantinovich MISORIN, Sergei Vasilyevich DIDUK, Anna Vladimirovna EROSHOVA, Veronika Sergeevna USATOVA, Elena Andreevna KRENDELEVA, Iakov Iurevich USTIUGOV, Aleksei Aleksandrovich ALEKSANDROV, Iana Andreevna SMIRNOVA, Svetlana Vladimirovna KOSKOVA, Roman Alekseevich IVANOV, Dmitry Valentinovich MOROZOV

Life of this patent

Estimating the term…

Abstract

The present invention relates to biotechnology and provides a monoclonal antibody that specifically binds to CD20. The invention also relates to DNA encoding said antibody, the corresponding expression vectors and methods of production thereof, as well as methods of treatment using said antibody.

Claims27

Dependent claims

A monoclonal antibody or antigen-binding fragment thereof that specifically binds to CD20 comprising:

1) a heavy chain variable domain comprising an amino acid sequence shown in SEQ ID NO:
2 or SEQ ID NO:
6;
2) a light chain variable domain comprising an amino acid sequence shown in SEQ ID NO:
4 or SEQ ID NO:
8.

3 more elements

Dependencies are inferred from the claim text.